Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Net Cash Flow (2017 - 2025)

Catheter Precision (VTAK) has disclosed Net Cash Flow for 9 consecutive years, with -$991000.0 as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 161.74% to -$991000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.8 million through Dec 2025, down 303.03% year-over-year, with the annual reading at -$2.8 million for FY2025, 303.03% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$991000.0 at Catheter Precision, down from $236000.0 in the prior quarter.
  • The five-year high for Net Cash Flow was $4.3 million in Q2 2021, with the low at -$8.0 million in Q1 2021.
  • Average Net Cash Flow over 5 years is -$1.2 million, with a median of -$1.2 million recorded in 2024.
  • The sharpest move saw Net Cash Flow plummeted 306.38% in 2021, then surged 538.64% in 2022.
  • Over 5 years, Net Cash Flow stood at -$5.6 million in 2021, then skyrocketed by 139.53% to $2.2 million in 2022, then plummeted by 191.46% to -$2.0 million in 2023, then skyrocketed by 179.69% to $1.6 million in 2024, then plummeted by 161.74% to -$991000.0 in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$991000.0, $236000.0, and $389000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.